Pathogen Reduction in Blood Products: What's Behind These Techniques?
作者信息
Janetzko Karin, Bugert Peter
机构信息
Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
出版信息
Transfus Med Hemother. 2011;38(1):5-6. doi: 10.1159/000324457.
Abstract
摘要
相似文献
1
Pathogen Reduction in Blood Products: What's Behind These Techniques?血液制品中的病原体灭活：这些技术背后是什么？
Transfus Med Hemother. 2011;38(1):5-6. doi: 10.1159/000324457.
2
[Monastery Medicine - What's the story behind it? What's reasonable, what's no good?].[寺院医学——其背后的故事是什么？哪些是合理的，哪些是不合理的？]
Dtsch Med Wochenschr. 2016 Dec;141(25):1858-1862. doi: 10.1055/s-0042-109417. Epub 2016 Dec 14.
3
Information overload: what's behind it, what's beyond it?信息过载：其背后是什么，又意味着什么？
Med J Aust. 2008 Jul 21;189(2):84-5. doi: 10.5694/j.1326-5377.2008.tb01922.x.
4
A commentary on the evolution of NIH: what's in, what's out, what's hot, what's not.关于美国国立卫生研究院发展历程的述评：哪些入选，哪些落选，哪些热门，哪些冷门。
Integr Physiol Behav Sci. 1998 Apr-Jun;33(2):115-7. doi: 10.1007/BF02688652.
5
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1994 Apr;7(2):203-4. doi: 10.1111/j.1540-8183.1994.tb00905.x.
6
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1992 Mar;5(1):67-8. doi: 10.1111/j.1540-8183.1992.tb00827.x.
7
Small animal dermatopathology: 'what's old, what's new, what's borrowed, what's useful'.小动物皮肤病理学：“旧闻、新闻、借鉴、实用”。
Semin Vet Med Surg Small Anim. 1987 Aug;2(3):162-5.
8
The Editor's Workshop: Pediatric and adolescent gynecology: What's the issue? What's the answer? What's the big picture? What's the national perspective?编辑工作室：儿科与青少年妇科：问题是什么？答案是什么？全局情况如何？全国视角怎样？
J Pediatr Adolesc Gynecol. 2009 Aug;22(4):195-6. doi: 10.1016/j.jpag.2009.06.001.
9
Update on health care in Canada: what's right, what's wrong, what's left.加拿大医疗保健最新情况：哪些方面做得对，哪些方面存在问题，以及未来走向。
J Public Health Policy. 1998;19(3):267-88.
10
Hospital-physician relationships: what's working, what's not working.医院与医生的关系：哪些方面行之有效，哪些方面存在问题。
Health Care Strateg Manage. 1999 Mar;17(3):18-20.
引用本文的文献
1
Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.迈向基于从脐带组织分离的间充质基质细胞的先进治疗药品：质量与安全数据。
Stem Cell Res Ther. 2014 Jan 17;5(1):9. doi: 10.1186/scrt398.
2
Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.血小板裂解液替代胎牛血清在间充质基质细胞培养中的应用。
Transfus Med Hemother. 2013 Oct;40(5):326-35. doi: 10.1159/000354061. Epub 2013 Aug 26.
本文引用的文献
1
The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma.溶剂/去污剂处理在血浆病原体灭活中的应用
Transfus Med Hemother. 2011;38(1):65-70. doi: 10.1159/000323552. Epub 2011 Jan 17.
2
Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.用于病原体灭活的THERAFLEX MB-血浆系统的主要特性
Transfus Med Hemother. 2011;38(1):55-64. doi: 10.1159/000323786. Epub 2011 Jan 27.
3
UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.紫外线C照射用于降低血小板浓缩物和血浆中的病原体
Transfus Med Hemother. 2011;38(1):43-54. doi: 10.1159/000323845. Epub 2011 Jan 22.
4
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.用于浓缩红细胞的S-303病原体灭活技术的研发。
Transfus Med Hemother. 2011;38(1):33-42. doi: 10.1159/000324458. Epub 2011 Jan 31.
5
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™.使用INTERCEPT血液系统™对用于输血的血小板和血浆血液成分进行病原体灭活。
Transfus Med Hemother. 2011;38(1):19-31. doi: 10.1159/000323937. Epub 2011 Jan 27.
6
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.使用核黄素和紫外线光对血小板、血浆和全血进行病原体灭活技术处理
Transfus Med Hemother. 2011;38(1):8-18. doi: 10.1159/000324160. Epub 2011 Jan 31.
7
Novel flow cytometry-based screening for bacterial contamination of donor platelet preparations compared with other rapid screening methods.基于新型流式细胞术的供体血小板制剂细菌污染筛查与其他快速筛查方法的比较。
Clin Chem. 2009 Aug;55(8):1492-502. doi: 10.1373/clinchem.2008.122515. Epub 2009 Jun 4.
8
Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up.血小板浓缩液的细菌污染筛查：检出细菌谱、输注单位比例及临床随访。
Ann Hematol. 2010 Jan;89(1):83-91. doi: 10.1007/s00277-009-0762-2. Epub 2009 May 30.
9
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.德国红十字会献血服务机构核酸检测经验：超过3000万次人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒献血筛查结果
Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.
10
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.血小板浓缩物的细菌污染：一项比较混合全血来源血小板和单采血小板的前瞻性多中心研究结果
Transfusion. 2007 Apr;47(4):644-52. doi: 10.1111/j.1537-2995.2007.01166.x.
Zotero 插件